Affiliation:
1. The Operation Eyesight Universal Institute for Eye Cancer L V Prasad Eye Institute Hyderabad India
2. Duke Eye Center Duke University Durham North Carolina USA
Abstract
AbstractIn the current era of global health awareness for retinoblastoma (RB), the challenge that lies ahead of us is providing optimal care for children affected with RB in underdeveloped nations. The understanding of similarities and disparities between various nations across the world aids in achieving comparable outcomes. With dissolving geographic barriers and evolving collaboration, global collaborative studies on RB are becoming increasingly common. They provide real‐world, robust evidence on several aspects of RB. This review discusses insights gained from global RB studies regarding the demographics, certain aspects of etiopathogenesis and epidemiology, international travel burden, disparities in clinical presentations based on national income levels, management protocols, pathology, treatment outcomes, and the effect of COVID‐19 on RB care across the world. These insights are likely to impact individual practice as well as inform policy reforms.
Funder
Hyderabad Eye Research Foundation
Operation Eyesight Universal Institute for Eye Cancer
Reference46 articles.
1. The story of retinoblastoma. The XX Edward Jackson memorial lecture;Dunphy EB;Am J Ophthalmol,1964
2. Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson memorial lecture;Grossniklaus HE;Am J Ophthalmol,2014
3. Genetics and molecular diagnostics in retinoblastoma—an update;Soliman SE;Asia Pac J Ophthalmol (Phila),2017
4. Chemoreduction in the initial management of intraocular retinoblastoma;Shields CL;Arch Ophthalmol,1996
5. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results;Shields CL;JAMA Ophthalmol,2014